We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Effective treatment of autoimmune thrombocytopenia with rituximab in CLL patient undergoing therapy with acalabrutinib.
- Authors
Iskierka-Jażdżewska, Elżbieta; Robak, Tadeusz
- Abstract
The article describes the case of a 74-year-old woman with leukocytosis with lymphocytosis with any other signs or symptoms where treatment-refractory immune thrombocytopenia (ITP) in chronic lymphocytic leukemia (CLL), during therapy with the Bruton's tyrosine kinase inhibitor acalabrunitib successfully responded to rituximab. Topics include the patient's diagnosis with high-risk CLL according to the Rai staging system, with secondary ITP and the optimal therapeutic strategy in CLL patients.
- Subjects
IDIOPATHIC thrombocytopenic purpura; CHRONIC leukemia; CHRONIC lymphocytic leukemia; RITUXIMAB; BRUTON tyrosine kinase
- Publication
Acta Haematologica Polonica, 2024, Vol 55, Issue 4, p224
- ISSN
0001-5814
- Publication type
Case Study
- DOI
10.5603/ahp.101337